Stock ENFN ENFUSION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Enfusion, Inc.

Equities

ENFN

US2928121043

Market Closed - Nyse
Other stock markets
 04:00:02 2024-06-05 pm EDT 		5-day change 1st Jan Change
9.16 USD +2.35% Intraday chart for Enfusion, Inc. -3.48% -5.57%
May. 22 Enfusion Insider Sold Shares Worth $325,263, According to a Recent SEC Filing MT
May. 09 Enfusion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 62% by 2026.
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.

Weaknesses

  • With an expected P/E ratio at 120.42 and 54.43 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • With an enterprise value anticipated at 3.83 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The company appears highly valued given the size of its balance sheet.
  • The company is highly valued given the cash flows generated by its activity.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Software

1st Jan change Capi. Investor Rating ESG Refinitiv
ENFUSION, INC. Stock Enfusion, Inc.
-5.57% 842M -
MICROSOFT CORPORATION Stock Microsoft Corporation
+12.76% 3,151B
C+
SYNOPSYS INC. Stock Synopsys Inc.
+14.22% 90.11B
B
CADENCE DESIGN SYSTEMS, INC. Stock Cadence Design Systems, Inc.
+8.83% 81.27B
B+
DASSAULT SYSTÈMES SE Stock Dassault Systèmes SE
-14.68% 53.72B
B+
PALANTIR TECHNOLOGIES INC. Stock Palantir Technologies Inc.
+33.72% 51.13B
D+
THE TRADE DESK, INC. Stock The Trade Desk, Inc.
+35.37% 47.65B
D+
ATLASSIAN CORPORATION Stock Atlassian Corporation
-33.62% 41.1B
B-
SEA LIMITED Stock Sea Limited
+75.63% 40.85B
D+
TAKE-TWO INTERACTIVE SOFTWARE, INC. Stock Take-Two Interactive Software, Inc.
+4.03% 28.7B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ENFN Stock
  4. Ratings Enfusion, Inc.